Orange Book product
ESCITALOPRAM OXALATE EQ 20MG BASE
Orange Book ANDA 215177 · ASCENT PHARMACEUTICALS INC · Prescription
Key facts
| Proprietary name | ESCITALOPRAM OXALATE |
|---|---|
| Active ingredients | ESCITALOPRAM OXALATE |
| Strength | EQ 20MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Application | ANDA215177 |
| Applicant holder | ASCENT PHARMACEUTICALS INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Jul 15, 2025 |
At a glance
- 10–99 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.